• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Respir J . Early renal impairment is associated with in-hospital death of patients with COVID-19

tetano

Editor, Senior Moderator
Clin Respir J


. 2022 May 19.
doi: 10.1111/crj.13496. Online ahead of print.
Early renal impairment is associated with in-hospital death of patients with COVID-19


Pei-Ling Bao[SUP] 1 [/SUP], Ke-Lan Deng[SUP] 2 [/SUP], An-Long Yuan[SUP] 3 [/SUP], Yi-Min Yan[SUP] 4 [/SUP], Ai-Qiao Feng[SUP] 4 [/SUP], Tao Li[SUP] 4 [/SUP], Xiao-An Liu[SUP] 5 [/SUP]



Affiliations

Abstract

Introduction: Renal impairment is a common complication in coronavirus disease 2019 (COVID-19), although its prognostic significance remains unknown.
Objectives: This study determines the impact of early renal impairment on the clinical outcome of COVID-19.
Methods: Patients diagnosed with COVID-19 and hospitalized in Xiaogan Central Hospital from 20 January to 29 February 2020 were retrospectively included and grouped into two cohorts (cohort with normal renal function and cohort with renal insufficiency) based on the renal function detected on admission. Records of clinical manifestation, laboratory findings and clinical outcome were collected and compared between these two cohorts.
Results: A total 543 COVID-19 patients were included. Among these patients, 70 patients developed early renal impairment, with an incidence of 12.89%. A significantly higher white blood cell (WBC) count, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), serum creatine (Cr), blood urine nitrogen (BUN) and brain natriuretic peptide (BNP) and a significantly lower blood platelet (PLT), lymphocyte count, prealbumin and albumin (ALB) were detected in the cohort with renal insufficiency (P < 0.05). Patients with early renal impairment were also associated with higher incidences of haematuria/proteinuria, higher incidences of mortality and prolonged hospitalization duration. The independent risk factors for in-hospital death included age >65 years old, complication of diabetes, renal impairment on admission (Cr > 73 μmol/L and eGFR < 60 ml/min 1.73 m[SUP]2[/SUP] ), WBC > 9.5 × 10[SUP]9[/SUP] /L and ALB < 35 g/L.
Conclusion: Early renal impairment is associated with higher risk of in-hospital death for patients with COVID-19. Risk stratification according to renal function can better guide the clinical management of COVID-19.

Keywords: COVID-19; eGFR; early renal impairment; mortality; pneumonia.
 
Back
Top Bottom